Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
RenJi Hospital
Seagen Inc.
The Netherlands Cancer Institute
NiKang Therapeutics, Inc.
Tempus AI
The Methodist Hospital Research Institute
Sichuan Baili Pharmaceutical Co., Ltd.
The Netherlands Cancer Institute